Literature DB >> 8609809

A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease.

Y Uchimura1, M Sata, M Kage, H Abe, K Tanikawa.   

Abstract

To clarify the relationship between hepatitis C virus infection and excessive alcohol intake, we carried out histological examination of the liver in 46 alcoholics with chronic hepatitis C virus infection and compared the findings in 55 patients with chronic hepatitis C, 38 with alcoholic liver disease, and 27 with chronic hepatitis B. The majority of alcoholics with chronic hepatitis C virus infection displayed virus-related histological changes very similar to those in chronic hepatitis C, including frequent lymphoid follicles (34.7%) or aggregates (93.3%) in the portal tracts, mild necroinflammatory change (76.1%) in the parenchyma, and lymphocytosis in sinusoids (83.7%). Liver cell dysplasia and irregular regenerative activity of hepatocytes were rarely observed. The effects of alcohol on the liver were found to be minimal in the majority. These findings could suggest that the hepatic injury in the majority of alcoholics with chronic hepatitis C virus infection in Japan is due to persistent hepatitis C virus infection rather than to alcoholic injury. In addition, our study disclosed that the perivenular fibrosis which is designated as a histological characteristic of alcoholic liver disease is frequently observed in chronic hepatitis C. These similarities suggest that a similar fibrogenesis is present in chronic hepatitis C and alcoholic liver disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8609809     DOI: 10.1111/j.1600-0676.1995.tb00689.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  13 in total

1.  Assessment of liver histology in chronic alcoholics with and without hepatitis C virus infection.

Authors:  S Anderson; C L Nevins; L K Green; H El-Zimaity; B S Anand
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

2.  Silencing a killer among us: ethanol impairs immune surveillance of activated stellate cells by natural killer cells.

Authors:  Gavin E Arteel
Journal:  Gastroenterology       Date:  2008-01       Impact factor: 22.682

3.  Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C.

Authors:  A M Zaitoun; H Al Mardini; S Awad; S Ukabam; S Makadisi; C O Record
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

4.  Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence.

Authors:  C O Bellamy; A M DiMartini; K Ruppert; A Jain; F Dodson; M Torbenson; T E Starzl; J J Fung; A J Demetris
Journal:  Transplantation       Date:  2001-08-27       Impact factor: 4.939

5.  Association of γ-glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV).

Authors:  James E Everhart; Elizabeth C Wright
Journal:  Hepatology       Date:  2013-04-05       Impact factor: 17.425

6.  Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis.

Authors:  Won-Il Jeong; Ogyi Park; Bin Gao
Journal:  Gastroenterology       Date:  2007-09-29       Impact factor: 22.682

Review 7.  Hepatitis C virus and alcohol.

Authors:  Larry Siu; Julie Foont; Jack R Wands
Journal:  Semin Liver Dis       Date:  2009-04-22       Impact factor: 6.115

8.  Positive CAGE screen correlates with cirrhosis in veterans with chronic hepatitis C.

Authors:  Ahmad Kamal; Ramsey Cheung
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.199

9.  Increase in alcohol related deaths: is hepatitis C a factor?

Authors:  J A Henry; C Moloney; C Rivas; R D Goldin
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

Review 10.  Inflammatory status in human hepatic cirrhosis.

Authors:  María Martínez-Esparza; María Tristán-Manzano; Antonio J Ruiz-Alcaraz; Pilar García-Peñarrubia
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.